Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Terra Property Trust, Inc. Releases Additional Information Related to Exchange Offers and Hires Restructuring Advisors
-
Autoscope Technologies Corporation Announces Financial Results
-
Abacus Global Management Announces Execution of Definitive Agreement To Acquire a Strategic Minority Investment in Manning & Napier
-
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
-
Abacus Global Management Announces Execution of Definitive Agreement To Acquire a Strategic Minority Investment in Manning & Napier
-
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
-
Oil-Dri’s Board of Directors Declares Quarterly Dividends
-
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
The Ensign Group to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 19, 2026
-
Open Lending Reports Fourth Quarter and Full Year 2025 Financial Results
-
Core Molding Technologies Announces $7,500,000 Stock Repurchase Program
-
VirTra Sets Fourth Quarter and Full Year 2025 Conference Call for Thursday, March 26, 2026 at 4:30 p.m. ET
-
Hallador Energy Company Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
Bimini Capital Management Announces Fourth Quarter and Full Year 2025 Results and Share Repurchase Plan
-
The Joint Corp. Reports 2025 Fourth Quarter and Full Year Financial Results
-
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
-
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
-
Zumiez Inc. Announces Fiscal 2025 Fourth Quarter Results
-
El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2025 Financial Results
-
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
-
Calavo Growers, Inc. Announces First Quarter 2026 Financial Results
-
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
-
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
-
Abacus Global Management Reports Fourth Quarter and Full Year 2025 Results
-
Picard Medical / SynCardia to Host Annual Business Update Featuring Key Opinion Leaders and Patient Testimonial
-
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
-
Jefferson Capital Reports Fourth Quarter and Full Year 2025 Results
-
Runway Growth Finance Corp. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
EverCommerce Announces Fourth Quarter and Full Year 2025 Financial Results
-
ServiceTitan Announces Fiscal Fourth Quarter and Full Fiscal Year 2026 Financial Results
-
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
-
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
-
Silvaco Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Robinhood Markets, Inc. Reports February 2026 Operating Data
-
Coherent Advances Scale-Across Networks with Significant Enhancements to Its Multi-Rail Transport Platform
-
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2025 Results
-
Mission Produce® Announces Fiscal 2026 First Quarter Financial Results
-
Karat Packaging Reports Fourth Quarter and Full Year 2025 Financial Results
-
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
-
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
-
Crane NXT Announces Appointment of Jeffrey Benck to Board of Directors
-
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
-
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
-
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
-
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
